Abstract
Purpose
Endometrial carcinoma with strong enhancement on dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is suggestive of high-grade type II endometrial carcinoma. However, low-grade type I endometrial carcinoma may also sometimes show strong enhancement. We hypothesized that squamous differentiation would contribute to the strong enhancement at the early phase on DCE-MRI-like uterine cervical squamous cell carcinoma and compared the DCE-MRI findings of endometrial carcinoma with and without squamous differentiation.
Methods
DCE-MRI of endometrial carcinoma including 41 low-grade type I endometrial carcinomas without squamous differentiation (LG), 39 low-grade type I endometrial carcinomas with squamous differentiation (LGSD), and 20 high-grade type II endometrial carcinomas (HG) was retrospectively evaluated.
Results
Significant difference in the time–intensity curves was found between LG and HG and LG and LGSD, whereas no significant difference was seen between HG and LGSD. Curve type 3 (initial signal rise which is steeper than that of the myometrium) was more frequent in HG (60%) and LGSD (77%) than in LG (34%).
Conclusion
It should be recognized as a pitfall that high-grade type II endometrial carcinoma and low-grade type I endometrial carcinoma with squamous differentiation may show similar early strong enhancement on DCE-MRI.
Graphical abstract
Similar content being viewed by others
References
Bosse T, Lortet-Tieulent J, Davidson B, Raspollini MR, Euscher ED, Singh N, Liu CR. (2020) Endometrioid carcinoma of the uterine corpus. In: the WHO Classification of Tumours Editorial Board (ed.) WHO Classification of Tumours: Female Genital Tumours, 5th edn. World Health Organization, Lyon, pp 252–255
Ellenson LH, Ronnett BM, Soslow RA, Lastra RR, Kurman RJ. (2019) Endometrial carcinoma. In: Kurman RJ, Ellenson LH, Ronnett BM. (eds.) Blaustein's Pathology of the Female Genital Tract, 7th edn. Springer, Cham, pp 473-533
Bokhman JV. (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17
Boronow RC, Morrow CP, Creasman WT, Disaia PJ, Silverberg SG, Miller A, Blessing JA. (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825-832
Prat J. (2004) Prognostic parameters of endometrial carcinoma. Hum Pathol 35:649-662
Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A. (2004) Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 108:425-432
Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. (2010) Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 375:1165-1172
Frumovitz M, Singh DK, Meyer L, Smith DH, Wertheim I, Resnik E, Bodurka DC. (2004) Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 95:463-468
Fukunaga T, Fujii S, Inoue C, Kato A, Chikumi J, Kaminou T, Ogawa T. (2015) Accuracy of semiquantitative dynamic contrast-enhanced MRI for differentiating type II from type I endometrial carcinoma. J Magn Reson Imaging 41:1662-1668
Yamashita Y, Takahashi M, Sawada T, Miyazaki K, Okamura H. (1992) Carcinoma of the cervix: dynamic MR imaging. Radiology 182:643-648
Thomassin-Naggara I, Bazot M, Darai E, Callard P, Thomassin J, Cuenod CA. (2008) Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology 248:148-159
Abulafia O, Triest WE, Sherer DM. (1999) Angiogenesis in malignancies of the female genital tract. Gynecol Oncol 72:220-231
Brasch RC, Li KC, Husband JE, Keogan MT, Neeman M, Padhani AR, Shames D, Turetschek K. (2000) In vivo monitoring of tumor angiogenesis with MR imaging. Acad Radiol 7:812-823
Dobrzycka B, Mackowiak-Matejczyk B, Kinalski M, Terlikowski SJ. (2013) Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma. Gynecol Oncol 128:454-460
Hirano Y, Kubo K, Hirai Y, Okada S, Yamada K, Sawano S, Yamashita T, Hiramatsu Y. (1992) Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms. Radiographics 12:243-256
Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H. (1993) Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 186:495-501
Joja I, Asakawa M, Asakawa T, Nakagawa T, Kanazawa S, Kuroda M, Togami I, Hiraki Y, Akamatsu N, Kudo T. (1996) Endometrial carcinoma: dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 20:878-887
Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Küsters-Vandevelde HVN, Matias-Guiu X, Amant F; ENITEC-consortium; Massuger LFAG, Bussink J, Pijnenborg JMA. (2019) Poor outcome in hypoxic endometrial carcinoma is related to vascular density. Br J Cancer. 120:1037-1044
Ye Z, Ning G, Li X, Koh TS, Chen H, Bai W, Qu H. (2022) Endometrial carcinoma: use of tracer kinetic modeling of dynamic contrast-enhanced MRI for preoperative risk assessment. Cancer Imaging. 22:14
Zinovkin DA, Pranjol MZI, Petrenyov DR, Nadyrov EA, Savchenko OG. (2017) The Potential Roles of MELF-Pattern, Microvessel Density, and VEGF Expression in Survival of Patients with Endometrioid Endometrial Carcinoma: A Morphometrical and Immunohistochemical Analysis of 100 Cases. J Pathol Transl Med. 51:456-462
Fasmer KE, Bjørnerud A, Ytre-Hauge S, Grüner R, Tangen IL, Werner HM, Bjørge L, Salvesen ØO, Trovik J, Krakstad C, Haldorsen IS. (2018) Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer. Acta Radiol. 59:1010-1017
Jansen JF, Koutcher JA, Shukla-Dave A. (2010) Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma. Angiogenesis. 13:149-160
Arakawa A, Tsuruta J, Nishimura R, Sakamoto Y, Korogi Y, Baba Y, Furusawa M, Ishimaru Y, Uji Y, Taen A, Ishikawa T, Takahashi M. (1996) Lingual carcinoma. Correlation of MR imaging with histopathological findings. Acta Radiol 37:700-707
Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S. (2014) Angiogenesis and antiangiogenic agents in cervical cancer. Onco Targets Ther. 3;7:2237-48
Stafl A, Mattingly RF. (1975) Angiogenesis of cervical neoplasia. Am J Obstet Gynecol. 121:845-851
Vici P, Mariani L, Pizzuti L, Sergi D, Di Lauro L, Vizza E, Tomao F, Tomao S, Mancini E, Vincenzoni C, Barba M, Maugeri-Saccà M, Giovinazzo G, Venuti A. (2014) Emerging biological treatments for uterine cervical carcinoma. J Cancer. 5:86-97
Smith-McCune KK, Weidner N. (1994) Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res. 54:800-804
Chinen K, Kamiyama K, Kinjo T, Arasaki A, Ihama Y, Hamada T, Iwamasa T. (2004) Morules in endometrial carcinoma and benign endometrial lesions differ from squamous differentiation tissue and are not infected with human papillomavirus. J Clin Pathol 57:918-926
Lucas E, Carrick KS. (2022) Low grade endometrial endometrioid adenocarcinoma: A review and update with emphasis on morphologic variants, mimics, immunohistochemical and molecular features. Semin Diagn Pathol 39:159-175
Zaino RJ, Kurman R, Herbold D, Gliedman J, Bundy BN, Voet R, Advani H. (1991) The significance of squamous differentiation in endometrial carcinoma. Data from a Gynecologic Oncology Group study. Cancer 68:2293-2302
Zaino RJ, Kurman RJ. (1988) Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma. Semin Diagn Pathol 5:154-171
Yan B, Zhao T, Liang X, Niu C, Ding C. (2018) Can the apparent diffusion coefficient differentiate the grade of endometrioid adenocarcinoma and the histological subtype of endometrial cancer? Acta Radiol 59:363-370
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Ethical approval
All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
For this type of study formal consent is not required, and the written informed consent of the patient was obtained for the MR examination.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Takeuchi, M., Matsuzaki, K., Bando, Y. et al. Dynamic contrast-enhanced MR imaging of uterine endometrial carcinoma with/without squamous differentiation. Abdom Radiol 48, 2494–2502 (2023). https://doi.org/10.1007/s00261-023-03934-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-023-03934-w